<DOC>
	<DOCNO>NCT00616954</DOCNO>
	<brief_summary>This study plan evaluate whether ATG need haploidentical stem cell transplantation</brief_summary>
	<brief_title>A Study Evaluate Effect ATG-F Engraftment , Graft Versus Host Disease ( GVHD ) Graft Versus Leukemia ( GVL ) Effect Haplo-identical SCT</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>1 . Patient age 370 year old disease necessitate allogeneic SCT . 2 . Patients must mismatch donor willing capable donate peripheral blood stem cell and/or bone marrow progenitor cell use conventional technique , lymphocyte indicate ( mismatch define 3/64/6 HLA matching ) . 3 . Each patient / patient 's guardian must sign write informed consent . 4 . Patients must ECOG PS â‰¤ 2 ; Creatinine &lt; 2.0 mg/dl ; Ejection fraction &gt; 40 % ; DLCO &gt; 50 % predict ; Serum bilirubin &lt; 3 gm/dl ; elevate GPT GOT &gt; 3 x normal value . 1 . Not fulfil inclusion criterion . 2 . Active lifethreatening infection . 3 . Overt untreated infection . 4 . Known hypersensitivity ATG . 5 . HIV seropositivity , Hepatitis B C antigen positivity evidence active hepatitis . 6 . Pregnant lactating woman . 7 . Donor contraindication ( HIV seropositive confirm Western Blot Hepatitis B antigenemia ; positive HCV antibody positive HCV PCR ; evidence bone marrow disease ; unable donate bone marrow peripheral blood due concurrent medical condition ) . 8 . Inability comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>mismatch</keyword>
	<keyword>Stem cell transplatation</keyword>
	<keyword>Bone marrow transplantation</keyword>
	<keyword>T cell depletion</keyword>
	<keyword>engraftment</keyword>
	<keyword>Patients undergo allogeneic haplo-SCT</keyword>
</DOC>